What Do Patients in Rheumatologic Care Know About the Risks of NSAIDs?

Ørnbjerg, Lykke Midtbøll; Andersen, Henning Boje; Kryger, P; Cleal, Bryan; Hetland, Merete Lund

doi:10.1097/rhu.0b013e31816b1e8e

Cited by 18 publications

(13 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Educational needs may be identified by the patients themselves as well as by HPs and should be regularly monitored. Educational and support needs may be most salient at times when patients are more likely to be experiencing change or pressure, such as in the early stages of their disease, when new pharmacological treatment is initiated and when their everyday life is affected 44 45. Differing educational needs may also appear when patients experience flares, worsening or comorbidities, and when the disease interferes with daily activities, life events and family roles 46–48…”

Section: Resultsmentioning

confidence: 99%

EULAR recommendations for patient education for people with inflammatory arthritis

et al. 2015

View full text Add to dashboard Cite

ObjectivesThe task force aimed to: (1) develop evidence-based recommendations for patient education (PE) for people with inflammatory arthritis, (2) identify the need for further research on PE and (3) determine health professionals' educational needs in order to provide evidence-based PE. Methods A multidisciplinary task force, representing 10 European countries, formulated a definition for PE and 10 research questions that guided a systematic literature review (SLR). The results from the SLR were discussed and used as a basis for developing the recommendations, a research agenda and an educational agenda. The recommendations were categorised according to level and strength of evidence graded from A (highest) to D (lowest). Task force members rated their agreement with each recommendation from 0 (total disagreement) to 10 (total agreement). Results Based on the SLR and expert opinions, eight recommendations were developed, four with strength A evidence. The recommendations addressed when and by whom PE should be offered, modes and methods of delivery, theoretical framework, outcomes and evaluation. A high level of agreement was achieved for all recommendations (mean range 9.4-9.8). The task force proposed a research agenda and an educational agenda. Conclusions The eight evidence-based and expert opinion-based recommendations for PE for people with inflammatory arthritis are intended to provide a core framework for the delivery of PE and training for health professionals in delivering PE across Europe.

show abstract

Section: Resultsmentioning

confidence: 99%

EULAR recommendations for patient education for people with inflammatory arthritis

et al. 2015

View full text Add to dashboard Cite

show abstract

“…Nevertheless, other sources such as drug information leaflets, internet, colleagues and pharmacist were equally important in providing details of the prescribed medications. 12,13,14,15 NSAIDs were prescribed for almost all arthritic patients either in regular or pro re nata basis irrespective of the rheumatological diagnosis. In our survey, rheumatoid arthritis patients receiving NSAIDs outnumbered other rheumatic disorders compared to the study conducted by Wynne and Long where NSAIDs were mostly prescribed for osteoarthritis followed by rheumatoid arthritis and other disorders.…”

Section: Discussionmentioning

confidence: 99%

Patient’s Knowledge and Perception Towards the use of Non-steroidal Anti-Inflammatory Drugs in Rheumatology Clinic Northern Malaysia

Sulaiman¹,

Seung²,

Ismail³

2012

Oman Med J

View full text Add to dashboard Cite

This study shows that half of the patients who attended the rheumatology clinic were unaware of the side effect of NSAIDs. Available data showed that most of the knowledgeable patients are more conscience and self-educated. This study also reveals the important roles of clinicians, trained staff nurses as well as the pharmacist in providing the guidance and knowledge of any medication taken by patients.

show abstract

“…As most rheumatologic diseases are dominated by pain, the most commonly used drugs are anti-inflammatory (5, 12); however, the side effects and risks of this therapeutic class appear to be little or poorly understood by many rheumatologic patients (13). These risks are related to the lack of possible control of dosages, duration of treatment, drug interactions, allergic or iatrogenic effects, and comorbidities.…”

Section: Discussionmentioning

confidence: 99%

Prevalence and factors associated with self-medication in rheumatology in Sub-Saharan Africa

Zabsonré

et al. 2015

Eur J Rheumatol

View full text Add to dashboard Cite

Objective: We sought to determine the prevalence of and factors associated with self-medication in patients with rheumatic diseases. Material and Methods: An analytical cross-sectional study was conducted from February to July 2013 in the rheumatology department.We included all patients who consulted for a rheumatic disease during the study period and who gave their consent.Results: In total, 203 patients were included; of these, 146 patients (71.92%) had practiced self-medication. Furthermore, 99 patients (48.8%) had practiced self-medication for rheumatologic problems. The mean age of the patients was 45.5 years (range: 18-75 years). State officials accounted for 44.4% of patients. Eighty-one patients were schooled. Low back pain (29.29%) was the main reason for consultation, followed by polyarthralgia (12.12%). Using a visual analogue scale, the level of pain for which patients had used self-medication was rated as >70 out of 100 in 57.6% of patients. Fifty-five patients often self-medicated and 28 patients rarely. Drugs were bought from the pharmacy in 97% of cases. The main channel of self-medication was word of mouth (43.4%). The drugs used were mainly anti-inflammatory drugs (diclofenac: 54.54% and ibuprofen: 57.57%). Ten patients were unaware of the risks of self-medication. In multivariate analysis, sex, education level, and occupation were statistically associated with self-medication. Conclusion:Self-medication for a specific rheumatologic symptom appears less common than self-medication in general. The procedures for responsible self-medication should be defined in Burkina Faso in order to minimize the risks.

show abstract

What Do Patients in Rheumatologic Care Know About the Risks of NSAIDs?

Abstract: Incomplete knowledge and misconceptions of some patients suggests that more information on risk factors and side effects to NSAID treatment is needed to improve patient safety. This is especially true about the combination of prescribed and OTC drugs.

Cited by 18 publications

References 13 publications

EULAR recommendations for patient education for people with inflammatory arthritis

EULAR recommendations for patient education for people with inflammatory arthritis

Patient’s Knowledge and Perception Towards the use of Non-steroidal Anti-Inflammatory Drugs in Rheumatology Clinic Northern Malaysia

Prevalence and factors associated with self-medication in rheumatology in Sub-Saharan Africa

Contact Info

Product

Resources

About